Studied variable | Baseline (before) | Day 2 (after) | Day 7 (after) | p value (Friedman test) |
---|---|---|---|---|
Total bilirubin (Mg/dl) | < 0.001* | |||
Mean ± SD | 12.01 ± 5.94 | 7.26 ± 4.10 | 3.09 ± 1.47 | |
Median (IQR) | 12.0 (10.8) | 6.70 (6.7) | 3.0 (2.2) | |
Min–max | 2.8–23.0 | 1.6 –16.5 | 0.8–7.90 | |
Direct bilirubin (Mg/dl) | < 0.001* | |||
Mean ± SD | 7.79 ± 4.43 | 5.74 ± 3.8 | 1.81 ± 1.17 | |
Median (IQR) | 8.0 (7.02) | 5.0 (5.07) | 1.9 (1.5) | |
Min–max | 1.5–19.0 | 0.40–15.0 | 0.20–6.0 | |
SGOT (U/L) | < 0.001 | |||
Mean ± SD | 167.73 ± 106.7 | 131.90 ± 3.75 | 90.64 ± 4.08 | |
Median (IQR) | 144.5 (136.0) | 27.0 (95) | 56.0 (79) | |
Min–max | 45–440 | 44–390 | 28–365 | |
SGPT(U/L) | < 0.001 | |||
Mean ± SD | 235.03 ± 145.6 | 159.6 ± 124.2 | 116.3 ± 1.3 | |
Median (IQR) | 204.5 (212) | 115.0 (172) | 99 (122) | |
Min–max | 44–814 | 44–740 | 13–544 | |
ALK (IU/L) | < 0.001 | |||
Mean ± SD | 447.8 ± 298.5 | 250.8 ± 198.7 | 212.6 ± 62.2 | |
Median (IQR) | 355.0 (324) | 199.5 (205) | 172.0 (119) | |
Min–max | 166–1626 | 44–1027 | 64–821 | |
GGT(U/L) | < 0.001 | |||
Mean±SD | 353.5 ± 201.14 | 302.7 ± 212.7 | 167.56 ± 01.28 | |
Median (IQR) | 321.0 (170) | 255.50 (162) | 155.0 (113) | |
Min–max | 74–972 | 65–1027 | 45–545 |